Figure 6.
Combined formestane (F) and herceptin (H) inhibit mRNA expression of HER1, HER2, and aromatase (CYP19) in testosterone treated CD44+/CD24low cells (C). The results obtained from RT‐PCR analysis were quantified by densitometry and are displayed in the lower graphs. Statistical differences obtained by comparison with untreated control (C). Error bars indicate SEM of triplicates. Statistical analysis was done by two‐tailed Student’s t‐test (*P < 0.01; **P < 0.001).